Grace H. McGregor

Grace H. McGregor

Auto-generated profile, based on publicly available information

Grace H. McGregor

Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABArnaud Blomme
Arnaud Blomme
CFCatriona A. Ford
Catriona A. Ford
EMErnest Mui
Ernest Mui
RPRachana Patel
Rachana Patel
CNChara Ntala
Chara Ntala
HLHing Leung
Hing Leung
Despite the clinical success of Androgen Receptor (AR)-targeted therapies, reactivation of AR signalling remains the main driver of castration-resistant prostate cancer (CRPC) progression. In this study, we perform a comprehensive unbiased characterisation of LNCaP cells chronically exposed to multiple AR inhibitors (ARI). Combined proteomics and metabolomics analyses implicate an acquired metabolic phenotype common in ARI-resistant cells and associated with perturbed glucose and lipid metabolism. To exploit this phenotype, we delineate a subset of proteins consistently associated with ARI resistance and highlight mitochondrial 2,4-dienoyl-CoA reductase (DECR1), an auxiliary enzyme of beta-oxidation, as a clinically relevant biomarker for CRPC. Mechanistically, DECR1 participates in redox homeostasis by controlling the balance between saturated and unsaturated phospholipids. DECR1 knockout induces ER stress and sensitises CRPC cells to ferroptosis. In vivo, DECR1 deletion impairs lipid metabolism and reduces CRPC tumour growth, emphasizing the importance of DECR1 in the development of treatment resistance.

15 January 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
GMGrace H. McGregor
Grace H. McGregor
ACAndrew D. Campbell
Andrew D. Campbell
SFSigrid K. Fey
Sigrid K. Fey
STSergey Tumanov
Sergey Tumanov
DSDavid Sumpton
David Sumpton
JKJurre J. Kamphorst
Jurre J. Kamphorst
Statins are widely prescribed inhibitors of the mevalonate pathway, acting to lower systemic cholesterol levels. The mevalonate pathway is critical for tumorigenesis and is frequently upregulated in cancer. Nonetheless, reported effects of statins on tumor progression are ambiguous, making it unclear whether statins, alone or in combination, can be used for chemotherapy. Here, using advanced mass spectrometry and isotope tracing, we showed that statins only modestly affected cancer cholesterol homeostasis. Instead, they significantly reduced synthesis and levels of another downstream product, the mitochondrial electron carrier coenzyme Q, both in cultured cancer cells and tumors. This compromised oxidative phosphorylation, causing severe oxidative stress. To compensate, cancer cells upregulated antioxidant metabolic pathways, including reductive carboxylation, proline synthesis, and cystine import. Targeting cystine import with an xCT transporter–lowering MEK inhibitor, in combination with statins, caused profound tumor cell death. Thus, statin-induced ROS production in cancer cells can be exploited in a combinatorial regimen. Significance: Cancer cells induce specific metabolic pathways to alleviate the increased oxidative stress caused by statin treatment, and targeting one of these pathways synergizes with statins to produce a robust antitumor response. See related commentary by Cordes and Metallo, p. 151

15 January 2020 in Cancer Research
Verified
Journal Article
Open access
PDF file
IKIrem Kaymak
Irem Kaymak
CMCarina Ramona Maier
Carina Ramona Maier
WSWerner Schmitz
Werner Schmitz
ACAndrew D. Campbell
Andrew D. Campbell
BDBeatrice Dankworth
Beatrice Dankworth
ASAlmut SChulze
Almut SChulze
Oncogene activation and loss of tumor suppressor function changes the metabolic activity of cancer cells to drive unrestricted proliferation. Moreover, cancer cells adapt their metabolism to sustain growth and survival when access to oxygen and nutrients is restricted, such as in poorly vascularized tumor areas. We show here that p53-deficient colon cancer cells exposed to tumor-like metabolic stress in spheroid culture activated the mevalonate pathway to promote the synthesis of ubiquinone. This was essential to maintain mitochondrial electron transport for respiration and pyrimidine synthesis in metabolically compromised environments. Induction of mevalonate pathway enzyme expression in the absence of p53 was mediated by accumulation and stabilization of mature SREBP2. Mevalonate pathway inhibition by statins blocked pyrimidine nucleotide biosynthesis and induced oxidative stress and apoptosis in p53-deficient cancer cells in spheroid culture. Moreover, ubiquinone produced by the mevalonate pathway was essential for the growth of p53-deficient tumor organoids. In contrast, inhibition of intestinal hyperproliferation by statins in an Apc/KrasG12D-mutant mouse model was independent of de novo pyrimidine synthesis. Our results highlight the importance of the mevalonate pathway for maintaining mitochondrial electron transfer and biosynthetic activity in cancer cells exposed to metabolic stress. They also demonstrate that the metabolic output of this pathway depends on both genetic and environmental context. Significance: These findings suggest that p53-deficient cancer cells activate the mevalonate pathway via SREBP2 and promote the synthesis of ubiquinone that plays an essential role in reducing oxidative stress and supports the synthesis of pyrimidine nucleotide.

5 May 2023 in Science Advances
Verified
Journal Article
Open access
RKRamya S. Kuna
Ramya S. Kuna
AKAvi Kumar
Avi Kumar
KWKarl A. Wessendorf-Rodriguez
Karl A. Wessendorf-Rodriguez
HGHector Galvez
Hector Galvez
CGCourtney R. Green
Courtney R. Green
CMChristian M. Metallo
Christian M. Metallo
Proliferating cells rely on acetyl-CoA to support membrane biogenesis and acetylation. Several organelle-specific pathways are available for provision of acetyl-CoA as nutrient availability fluctuates, so understanding how cells maintain acetyl-CoA homeostasis under such stresses is critically important. To this end, we applied 13 C isotope tracing cell lines deficient in these mitochondrial [ATP-citrate lyase (ACLY)]–, cytosolic [acetyl-CoA synthetase (ACSS2)]–, and peroxisomal [peroxisomal biogenesis factor 5 (PEX5)]–dependent pathways. ACLY knockout in multiple cell lines reduced fatty acid synthesis and increased reliance on extracellular lipids or acetate. Knockout of both ACLY and ACSS2 (DKO) severely stunted but did not entirely block proliferation, suggesting that alternate pathways can support acetyl-CoA homeostasis. Metabolic tracing and PEX5 knockout studies link peroxisomal oxidation of exogenous lipids as a major source of acetyl-CoA for lipogenesis and histone acetylation in cells lacking ACLY, highlighting a role for inter-organelle cross-talk in supporting cell survival in response to nutrient fluctuations.

15 September 2022 in Journal of Lipid Research
Verified
Journal Article
Open access
TCThekla Cordes
Thekla Cordes
RKRamya S. Kuna
Ramya S. Kuna
GMGrace H. McGregor
Grace H. McGregor
SKSanika V. Khare
Sanika V. Khare
JGJivani Gengatharan
Jivani Gengatharan
CMChristian M. Metallo
Christian M. Metallo
Serine palmitoyltransferase (SPT) predominantly incorporates serine and fatty acyl-CoAs into diverse sphingolipids (SLs) that serve as structural components of membranes and signaling molecules within or amongst cells. However, SPT also uses alanine as a substrate in the contexts of low serine availability, alanine accumulation, or disease-causing mutations in hereditary sensory neuropathy type I, resulting in the synthesis and accumulation of 1-deoxysphingolipids (deoxySLs). These species promote cytotoxicity in neurons and impact diverse cellular phenotypes, including suppression of anchorage-independent cancer cell growth. While altered serine and alanine levels can promote 1-deoxySL synthesis, they impact numerous other metabolic pathways important for cancer cells. Here, we combined isotope tracing, quantitative metabolomics, and functional studies to better understand the mechanistic drivers of 1-deoxySL toxicity in cancer cells. We determined that both alanine treatment and SPTLC1C133W expression induce 1-deoxy(dihydro)ceramide synthesis and accumulation but fail to broadly impact intermediary metabolism, abundances of other lipids, or growth of adherent cells. However, we found that spheroid culture and soft agar colony formation were compromised when endogenous 1-deoxySL synthesis was induced via SPTLC1C133W expression. Consistent with these impacts on anchorage-independent cell growth, we observed that 1-deoxySL synthesis reduced plasma membrane endocytosis. These results highlight a potential role for SPT promiscuity in linking altered amino acid metabolism to plasma membrane endocytosis.

28 October 2024 in Journal of Lipid Research
Verified
Journal Article
Open access
CGCourtney R. Green
Courtney R. Green
MKMatthew J. Kolar
Matthew J. Kolar
GMGrace H. McGregor
Grace H. McGregor
ANAndrew T. Nelson
Andrew T. Nelson
Martina WallaceMartina Wallace
Martina Wallace
CMChristian M. Metallo
Christian M. Metallo
Compound lipids comprise a diverse group of metabolites present in living systems, and metabolic- and environmentally-driven structural distinctions across this family are increasingly linked to biological function. However, methods for deconvoluting these often isobaric lipid species are lacking or chain diversity within cells may be influenced by nutritional states, metabolic dysregulation, or genetic alterations. Therefore, a reliable, validated method of quantifying structurally similar even-, odd-, and branched-chain acyl groups within intact compound lipids will be invaluable for gaining molecular insights into their biological functions. Here we demonstrate the chromatographic resolution of isobaric lipids containing distinct combinations of straight-chain and branched-chain acyl groups via mass spectrometry (MS) using a C30 liquid chromatography column. Using metabolically engineered A (Bckdha), we validate this approach through a combination of fatty acid supplementation and fatty acids and valine. We observe the resolution of pound lipids, demonstrating the resolving utility of this method.(jlr) This approach adds to the toolbox for diversity across the lipidome.